1491PA phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trial. (23rd October 2018) - Kinoshita, I; Goda, T; Watanabe, K; Maemondo, M; Oizumi, S; Amano, T; Hatanaka, Y; Matsuno, Y; Nishihara, H; Asahina, H; Harada, T; Goto, K; et al.